-
Targeting lipid and energy metabolism for cardiovascular diseases
이은우 한국생명공학연구원 대사제어연구센터 12:00~12:20 -
Next generation NAD⁺ therapeutics via new modalities
류동렬 GIST 의생명공학과 12:20~12:40 -
Development of cardiovascular therapeutics through regulation of endothelial dysfunction
장우철 부산대 생물교육과 12:40~13:00 - Panel Discussion 13:00~13:20
-
Genetic and mechanistic insights into triglyceride-rich lipoproteins and cardiometabolic disease
김병진 성균관의대 순환기내과 13:50~14:08 -
Omega-3 fatty acids: from triglyceride reduction to cardiovascular outcomes
임수 서울의대 내분비대사내과 14:08~14:26 -
APOC3 metabolism and therapeutic approaches
김남훈 고려의대 내분비내과 14:26~14:44 -
ANGPTL3/4/8 inhibition: translational insights and clinical development
정혜문 경희의대 심장내과 14:44~15:02 - Panel Discussion 15:02~15:20
-
How should we apply the 2025 dyslipidemia guidelines in real-world Korean practice?
윤종찬 가톨릭의대 순환기내과 15:20~15:40 -
Early and intensive lipid-Lowering after acute coronary syndrome: timing, targets, and real-world challenges
임수빈 이화의대 순환기내과 15:40~16:00 -
Managing residual atherosclerotic risk: beyond LDL-C toward precision lipid therapy
이수연 단국의대 심장혈관내과 16:00~16:20 - Panel Discussion 16:20~16:50